Beverely Hills, CACIK 20393491 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
13 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Kyverna Therapeutics Inc | 4.39M | $41.28M | 29.6% | +4.39M | New Position |
| 2 | Teva Pharmaceutical Inds Ltd | 769.5K | $24.02M | 17.2% | +769.5K | New Position |
| 3 | Bausch Plus Lomb Corp | 613.5K | $10.48M | 7.5% | +613.5K | New Position |
| 4 |
| Crinetics Pharmaceuticals In |
| 224.1K |
| $10.43M |
| 7.5% |
| +224.1K |
| New Position |
| 5 | Amgen Inc | 23.2K | $7.60M | 5.4% | +23.2K | New Position |
| 6 | Ultragenyx Pharmaceutical In | 329.1K | $7.57M | 5.4% | +329.1K | New Position |
| 7 | Taysha Gene Therapies Inc | 1.33M | $7.32M | 5.2% | +1.33M | New Position |
| 8 | Vir Biotechnology Inc | 930.3K | $5.61M | 4.0% | +930.3K | New Position |
| 9 | Tarsus Pharmaceuticals Inc | 66.7K | $5.46M | 3.9% | +66.7K | New Position |
| 10 | Incyte Corp | 54.5K | $5.38M | 3.9% | +54.5K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio